RHEUMATOID ARTHRITIS TREATMENTS News, Sports, Shopping, Travel information

Arthritis Treatment
Find: Arthritis Treatment. Review & Compare!
www.findstuff.com

European Commission Approval Of New Indication For Roche’s Pegasys ... - Webwire
pegasys is the first and only pegylated interferon to be approved for treatment of up to 72 weeks in treatment-experienced patients roche announced today that the european commission has approved pegasys (peginterferon alfa-2a [40 kd]) plus copegus ...
www.webwire.com

(afx Uk Focus) 2008-12-04 08:38 Update 2-u.s. Fda Seeks More Data On Roche Arthritis Drug
zurich, dec 4 (reuters) - the u.s. food and drug administration (fda) has asked for further non-clinical data on roche holding ag's rheumatoid arthritis drug actemra before it approves the potential blockbuster. the swiss group said on thursday the fda had requested additional animal model data but ordered no further clinical studies, and that the company would submit the required information in ...
www.iii.co.uk

Correspondence: Adalimumab In Juvenile Rheumatoid Arthritis
to the editor: lovell et al. (aug. 21 issue)1 report that adalimumab seems to be effective in the treatment of ...
content.nejm.org

Roche And Fda Agree On Pathway Towards U.s. Approval Of Actemra ... - Webwire
swissmedic today approved actemra for use in rheumatoid arthritis roche today announced that the u.s. food and drug administration (fda) has provided further guidance on the requirements for the biologics license application (bla) for actemra ...
www.webwire.com

Adalimumab In Juvenile Rheumatoid Arthritis - New England Journal Of Medicine
to the editor: lovell et al. (aug. 21 issue) 1 report that adalimumab seems to be effective in the treatment of children with juvenile rheumatoid arthritis. however, interpretation of their results is difficult, given the medication-withdrawal design ...
content.nejm.org

Roche And Fda Agree On Pathway Towards U.s. Approval Of Actemra(r) (tocilizumab)
roche today announced that the u.s. food and drug administration has provided further guidance on the requirements for the biologics license application for actemra® , the first interleukin-6 receptor-inhibiting monoclonal antibody studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis .
biz.yahoo.com

Results From The First And Largest Collaborative Study Confirm Role Of Enbrel® In Psoriatic Arthritis
new data presented today at the 'gene to clinic' meeting taking place at the royal college of physicians in london, england, reinforce enbrel's ability to clear skin in patients with psoriatic arthritis, an inflammatory and progressive disease associated with psoriasis.
www.medicalnewstoday.com

Results From The First And Largest Collaborative Study Confirm Role Of ... - Msn Moneycentral
maidenhead, england , december 4 /prnewswire/ -- new data presented today at the 'gene to clinic' meeting taking place at the royal college of physicians in london, england , reinforce enbrel's ability to clear skin in patients with psoriatic ...
news.moneycentral.msn.com

Investors Support Danish Arthritis Drug Hope - Biotech Sweden
the biotech company cytoguide has received dkk 14 million from four danish and swedish investors to further develop a treatment for rheumatoid arthritis. the aarhus based cytoguide gets support from the investors novo, østjysk innovation, karolinska ...
biotech.idg.se

Biomed Start-up Protab Gears Antibody For Diabetes, Arthritis Treatment
the hadasit bio holdings company is now planning a phase i clinical study.
www.globes.co.il

Who Tool Helps Target Bone Treatment
new method will help physicians better identify patients at high risk of fracture better targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide. a new method1 for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by the national osteoporosis guideline group in the uk.
www.medicalnewstoday.com

Roche And Fda Agree On Pathway Towards U.s. Approval Of Actemra(r ... - Yahoo Finance
nutley, n.j., dec. 4 /prnewswire/ -- roche today announced that the u.s. food and drug administration (fda) has provided further guidance on the requirements for the biologics license application (bla) for actemra® (tocilizumab), the first ...
biz.yahoo.com

Roche: Fda Provides Further Guidance On Actemra Path - Beurs.nl
zurich -(dow jones)- swiss drugmaker roche holding ag (rhhby) said thursday that the u.s. food and drug administration has provided further guidance on the requirements for the biologics license application for actemra, which is meant for the ...
www.beurs.nl

Better Targeted, More Cost-effective Osteoporosis Treatment Could Soon Be A Reality Worldwide
a new method for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by the national osteoporosis guideline group in the uk.
www.news-medical.net

Biomonitor Acquires The Irish Theranostic Company Neutekbio
biomonitor a/s has completed the acquisition of the irish company neutekbio ltd. on 27 november 2008. neutekbio's technologies and products complement perfectly biomonitor's current offerings to physicians and clinics involved in treatment of patients with multiple sclerosis, rheumatoid arthritis and crohn's disease worldwide.
biz.yahoo.com

Arthritis Research Shows Better Management More Important Than New ... - Science Daily
sciencedaily (dec. 2, 2008) — although there has been an increase in the number of new arthritis treatments in recent years, the best results will come from more effective use of the drugs we have. new research investigates the effectiveness of ...
www.sciencedaily.com

Better Management More Important Than New Drugs For Arthritis - Medical News Today
although there has been an increase in the number of new arthritis treatments in recent years, the best results will come from more effective use of the drugs we have. research published in biomed central's open access journal arthritis research and ...
www.medicalnewstoday.com

Roche Hit As Fda Seeks More Data On Arthritis Drug
* u.s. regulators ask for more data on actemra
malaysia.news.yahoo.com

Who Tool Helps Target Bone Treatment
( springer ) better-targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide. a new method for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by the national osteoporosis guideline group in the uk.
www.eurekalert.org

Update 3-roche Hit As Fda Seeks More Data On Arthritis Drug - Cnbc
by katie reid zurich, dec 4 (reuters) - u.s. approval for roche holding ag's actemra has been delayed further after regulators asked for more non-clinical data on the potential blockbuster rheumatoid arthritis drug. the swiss group said on thursday ...
www.cnbc.com